Company / Interest Expense
Boston Scientific Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$349.0M
FY2025
5-year range
$265.0M / $473.0M
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#10 of 44
Health Care
What the data says
Boston Scientific's interest expense of $349M is higher than 77% of companies in the Health Care sector (FY2025). Interest Expense has fluctuated over the past 10 years, ranging from $229M in FY2017 to $473M in FY2021.
Based on SEC 10-K filings.
$349M in FY2025 with a 5-year CAGR of +7.7%. Top quartile in the Health Care sector.
Increased from $265M to $349M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
+10.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.7%, indicating consistent growth.
- In FY2025, interest expense increased 14.4% year-over-year.
- Ranks #10 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $349.0M | +14.4% |
| FY2024 | $305.0M | +15.1% |
| FY2023 | $265.0M | -43.6% |
| FY2022 | $470.0M | -0.6% |
| FY2021 | $473.0M | +96.3% |
| FY2020 | $241.0M | -49.0% |
| FY2019 | $473.0M | +96.3% |
| FY2018 | $241.0M | +5.2% |
| FY2017 | $229.0M | -1.7% |
| FY2016 | $233.0M | -18.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026